Apple (NSDQ:AAPL) has acquired pediatric asthma monitoring start-up Tueo Health, according to a recent CNBC report.
Tueo Health was founded out of a Stanford-based incubator in 2015, according to a Stanford Byers Center for Biodesign posting, and was developing a mobile application intended to operate with commercial breathing sensors to monitor and help manage asthma symptoms in children.
The app is designed to alert parents if breathing changes at night, according to the CNBC report.
Financial details of the acquisition were not released, though Tueo Health reported raising a small seed round of $1.1 million in 2017, according to the report.
The deal likely closed in late 2018, as Tueo Health co-founder & CEO Brownyn Harris and COO Anura Patil changed their employers to Apple on their LinkedIn profiles during that timeframe, according to CNBC.
Apple has not yet officially commented on the acquisition.
In April, a group of Morgan Stanley analysts estimated that Apple’s opportunity in the U.S. healthcare market could be up to three times larger than the global smartphone market.